- 2025/6/19Estradiol 17-(β-D-Glucuronide) sodium,15087-02-2,99.46%
- 2025/6/19PROTAC ERα Degrader-4,2521299-80-7,99.06%
- 2025/6/19Bexirestrant,2505067-70-7,99.46%
- 2025/6/19Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT,2396667-62-0,98.19%
- 2025/6/19TNF-α-IN-6,2699704-20-4,99.55%
- 2025/6/19PRGL493,2479378-45-3,99.56%
- 2025/6/19Phosphatidylcholines,soya,大豆磷脂酰胆碱,97281-47-5,99.08%
- 2025/6/19EGTA-AM,99590-86-0
- 2025/6/19Mal-VC-PAB-DM1,1464051-44-2,99.41%
- 2025/6/19SY-5609,2417302-07-7,99.33%
- 2025/6/19Aldosterone-d7,醛固酮 d7,99.78%
- 2025/6/19Banoxantrone dihydrochloride,252979-56-9,99.46%
- 2025/6/19GW1929,196808-24-9,99.93%
- 2025/6/19法瑞西单抗,Faricimab,1607793-29-2
- 2025/6/19NF-κΒ activator 1,2387524-59-4,99.59%
- 2025/6/19Carfilzomib,卡非佐米,868540-17-4,99.98%
- 2025/6/19SN-38-d3,718612-49-8,99.07%
- 2025/6/19Vipivotide tetraxetan,1702967-37-0,99.46%
- 2025/6/19Kartogenin,4727-31-5,99.05%
- 2025/6/18Pyrotinib,吡咯替尼,1269662-73-8,99.89%
- 2025/6/18Cadisegliatin,859525-02-3,99.10%
- 2025/6/18C16-Ceramide,24696-26-2,≥99.0%
- 2025/6/18Rocaglamide,楝酰胺,84573-16-0,99.34%
- 2025/6/18Kisspeptin-54(human),374683-24-6,98.00%
- 2025/6/18吉妥珠单抗,Gemtuzumab,220578-59-6,99.54%
- 2025/6/18α,β-Methylene-ATP trisodium,1343364-54-4,99.75%